Association of All-cause Mortality with Pre-dialysis Systolic Blood Pressure and Its Peridialytic Change in Chronic Hemodialysis Patients
Overview
Nephrology
Authors
Affiliations
Background: Pre-dialysis systolic blood pressure (pre-HD SBP) and peridialytic SBP change have been associated with morbidity and mortality among hemodialysis (HD) patients in previous studies, but the nature of their interaction is not well understood.
Methods: We analyzed pre-HD SBP and peridialytic SBP change (calculated as post-HD SBP minus pre-HD SBP) between January 2001 and December 2012 in HD patients treated in US Fresenius Medical Care facilities. The baseline period was defined as Months 4-6 after HD initiation, and all-cause mortality was noted during follow-up. Only patients who survived baseline and had no missing covariates were included. Censoring events were renal transplantation, modality change or study end. We fitted a Cox proportional hazard model with a bivariate spline functions for the primary predictors (pre-HD SBP and peridialytic SBP change) with adjustment for age, gender, race, diabetes, access-type, relative interdialytic weight gain, body mass index, albumin, equilibrated normalized protein catabolic rate and ultrafiltration rate.
Results: A total of 172 199 patients were included. Mean age was 62.1 years, 61.6% were white and 55% were male. During a median follow-up of 25.0 months, 73 529 patients (42.7%) died. We found that a peridialytic SBP rise combined with high pre-HD SBP was associated with higher mortality. In contrast, when concurrent with low pre-HD SBP, a peridialytic SBP rise was associated with better survival.
Conclusion: The association of pre-HD and peridialytic SBP change with mortality is complex. Our findings call for a joint, not isolated, interpretation of pre-HD SBP and peridialytic SBP change.
Stenberg J, Sandberg O, Marttala K, Svensson M J Ren Care. 2025; 51(1):e70009.
PMID: 39905984 PMC: 11795226. DOI: 10.1111/jorc.70009.
Mora-Bravo F, Torres P, Campoverde N, Carcelen G, Mancheno J, Tipanta A BMC Nephrol. 2025; 26(1):30.
PMID: 39825259 PMC: 11742504. DOI: 10.1186/s12882-025-03948-0.
Xu H, Wang X, Feng M, Chen L Int J Gen Med. 2024; 17:4781-4791.
PMID: 39440103 PMC: 11495203. DOI: 10.2147/IJGM.S479035.
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.
Guo L, Ji Y, Sun T, Liu Y, Jiang C, Wang G Rev Cardiovasc Med. 2024; 25(6):232.
PMID: 39076321 PMC: 11270084. DOI: 10.31083/j.rcm2506232.
Moloney B, Chertow G, Mc Causland F Am J Nephrol. 2024; 55(4):409-416.
PMID: 38781949 PMC: 11305924. DOI: 10.1159/000539451.